Opinion ID: 4151593
Heading Depth: 2
Heading Rank: 11

Heading: Andrea Rupert

Text: Plaintiff Andrea Rupert received her ObTape implant in May 2004. She suffered groin pain, vaginal discharge, foul odor, a thigh abscess, and other complications. Her infected ObTape was removed in June 2005. After seeing an advertisement regarding transvaginal mesh litigation, Rupert filed her complaint in March 2013. Rupert notes that her doctor informed her that her body was not adapting well to the mesh. Rupert also alleges that she engaged in an extraordinary investigation to find the cause of her injury. Before surgery, she read the brochure for ObTape and these risks were not listed. After her ObTape became infected, she 18 Case: 16-10119 Date Filed: 03/09/2017 Page: 19 of 28 even communicated with Mentor. Rupert spoke with an ObTape marketing manager at her excision surgery, who informed her that the product was safe and led her to believe the product was not the cause of her injuries. 3 Mentor does not refute this and just points out that Rupert knew she was having complications with her ObTape when it was removed. The district court explained that “in August 2005, Rupert visited [a] doctor, who noted that Rupert was concerned that half of her ObTape was still in her body and that it may become infected. Thus, by August 2005, Rupert connected her injuries to ObTape.” Id. at .